or Try an Advanced Search...

    Ocular Hypertension Stocks List

    Symbol Grade Name % Change
    ABBV C AbbVie Inc. 0.80
    OCUL D Ocular Therapeutix, Inc. -13.48
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Adalimumab Advanced Prostate Cancer Allergic Conjunctivitis Allergology Anemia Atopic Dermatitis Autoimmune Disease Blood Cancers Cataract Surgery Cataracts Chronic Idiopathic Constipation Clinical Trial Combination Drugs Constipation Cornea Crohn's Disease Depressive Disorder Endometriosis Eye Eye Care Products

    Related ETFs - A few ETFs which own one or more of the above listed Ocular Hypertension stocks.

    Symbol Grade Name Weight
    MEDI C Harbor Health Care ETF 9.87
    HDLB C ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 9.8
    BOTZ C Global X Robotics & Artificial Intelligence Thematic ETF 8.13
    MEDX F Horizon Kinetics Medical ETF 7.88
    GRID A First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund 7.8
    View all Ocular Hypertension ETFs...
    Compare ETFs
    Compare BOTZ to GRID Compare BOTZ to MEDX Compare HDLB to MEDX

        Ocular Hypertension Stocks Recent News

        Date Stock Title
        Apr 19 ABBV The Bad News Heading Into AbbVie's First-Quarter Earnings Report
        Apr 19 ABBV Earnings Preview: AbbVie (ABBV) Q1 Earnings Expected to Decline
        Apr 19 ABBV Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
        Apr 18 ABBV Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson's Disease Study
        Apr 18 OCUL Ocular Therapeutix Highlights Early Data From Diabetes-Related Eye Disorder
        Apr 18 ABBV AbbVie Q1 Earnings Preview: No Repeat Of Last Year's Q1 Disappointment
        Apr 18 ABBV Heard on the Street: AbbVie’s Bet on a Neuroscience Drug Maker Just Got Better
        Apr 18 ABBV AbbVie succeeds in late-stage trial for Rinvoq in inflammatory condition
        Apr 18 ABBV Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis
        Apr 18 OCUL Ocular marks early-stage trial win for diabetic retinopathy candidate
        Apr 18 ABBV AbbVie buyout Cerevel posts late-stage win for Parkinson’s disease drug
        Apr 18 OCUL Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy
        Apr 18 ABBV Cerevel, in ‘major surprise,’ finds success in late-stage Parkinson’s study
        Apr 17 ABBV AbbVie (ABBV) Increases Despite Market Slip: Here's What You Need to Know
        Apr 17 ABBV CVS favors Humira copycats hurting AbbVie’s market share: Evercore
        Apr 16 ABBV AbbVie: Through Humira's Crisis Towards Solid Growth
        Apr 16 ABBV AbbVie to develop long-acting injectables in a deal worth up to $1.9B
        Apr 16 ABBV AbbVie working with FDA after reports of fake Botox versions
        Apr 16 ABBV UPDATE 1-US FDA warns of harmful reactions to fake Botox injections
        Apr 16 ABBV Johnson & Johnson (JNJ) Q1 Earnings Top Estimates
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Adalimumab Advanced Prostate Cancer Allergic Conjunctivitis Allergology Anemia Atopic Dermatitis Autoimmune Disease Blood Cancers Cataract Surgery Cataracts Chronic Idiopathic Constipation Clinical Trial Combination Drugs Constipation Cornea Crohn's Disease Depressive Disorder Endometriosis Eye Eye Care Products
        Ocular Hypertension

        Browse All Tags